DuraVest, Inc.

Cardio Management Systems to increase its ownership in Estracure

Published in Cardiovascular Business Week, December 14th, 2004

DuraVest, Inc., (DUVT) announced that it coordinated and assisted in arranging financing of CDN$7.5 million for Cardio Management Systems, Inc., (Cardio) which Cardio will use to increase its investment in Estracure, Inc.

In 2001, Cardio acquired 26% of Estracure for CDN$2.5 million. Estracure used those funds to begin clinical trials at five sites in Canada, assessing the validity of the use of estradiol with drug-eluting stents

Cardio will acquire an additional 25% of Estracure for CDN$7.5 million bringing its ownership of Estracure to approximately 51%.

Pursuant to a conditional stock exchange agreement dated April 4, 2002 as...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cardiovascular Business Week

Source: Cardiovascular Business Week (2004-12-14)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry